secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-08-26T23:59:59+00:00
Accession:  0001193125-25-188075
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics regains Nasdaq compliance on two listing rules; bid price deadline extended to Nov 12, 2025
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with MVLS ($35M) and equity ($2.5M) standards on Aug 22, 2025.
- Bid price rule deadline extended to Nov 12, 2025; prior Sept 8 deadline no longer applies.
- One-year monitoring for equity standard through Aug 22, 2026; breach triggers delist process without cure period.
- Company now satisfies two alternative criteria under Nasdaq Listing Rule 5550.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/0001193125-25-188075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/d919644d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-188075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer